Purpose: We set out to characterize the pattern of fundus autofluorescence (AF) loss in choroideremia (CHM) patients of varying ages and disease severity in order to determine the average rate of progression of this potential disease biomarker. Methods: Fifty consecutive CHM patients (100 eyes) attending outpatient clinics at Oxford Eye Hospital underwent analysis with the Heidelberg OCT Spectralis with autofluorescence capabilities. The area of residual AF was traced using Heidelberg Eye Explorer. Bland-Altman analysis was used to calculate the coefficient of repeatability (CR). The degree of AF loss was correlated to different ages and the pattern of residual AF constructed into color-coded maps in order to gain insight into the mechanism...
Purpose: To characterize defects in color vision in patients with choroideremia.Design: Prospective ...
PURPOSE:To describe and classify patterns of abnormal fundus autofluorescence (FAF) of patients with...
Purpose: Centripetal retinal degeneration in choroideremia (CHM) leads to early visual field restric...
Purpose The purpose of this study was to investigate fundus autofluorescence lifetimes in patient...
Item does not contain fulltextBACKGROUND/AIMS: To better understand the pattern of degeneration prog...
PURPOSE: To evaluate the relationships between RPE, photoreceptor, and choroidal degeneration in cho...
PURPOSE: To identify valid and reproducible methods for quantifying anatomic outcome measures for ey...
PURPOSE To quantify retinal fluorescence lifetimes in patients with central serous chorioretinopa...
Fundus autofluorescence (AF) arises from lipofuscin, which is derived from retinoid byproducts of th...
PURPOSE: To describe and classify patterns of abnormal fundus autofluorescence (FAF) in eyes with ea...
PURPOSE: To test the hypothesis that the extension of areas with increased fundus autofluorescence (...
Purpose: To investigate the autofluorescence lifetimes as well as spectral characteristics of soft d...
PURPOSE. To evaluate the relationships between RPE, photoreceptor, and choroidal degeneration in cho...
PURPOSE:To assess the 5-year change in abnormal fundus autofluorescence (FAF) patterns and retinal s...
Purpose: to investigate the pattern of fundus autofluorescence and the correlation with the genotyp...
Purpose: To characterize defects in color vision in patients with choroideremia.Design: Prospective ...
PURPOSE:To describe and classify patterns of abnormal fundus autofluorescence (FAF) of patients with...
Purpose: Centripetal retinal degeneration in choroideremia (CHM) leads to early visual field restric...
Purpose The purpose of this study was to investigate fundus autofluorescence lifetimes in patient...
Item does not contain fulltextBACKGROUND/AIMS: To better understand the pattern of degeneration prog...
PURPOSE: To evaluate the relationships between RPE, photoreceptor, and choroidal degeneration in cho...
PURPOSE: To identify valid and reproducible methods for quantifying anatomic outcome measures for ey...
PURPOSE To quantify retinal fluorescence lifetimes in patients with central serous chorioretinopa...
Fundus autofluorescence (AF) arises from lipofuscin, which is derived from retinoid byproducts of th...
PURPOSE: To describe and classify patterns of abnormal fundus autofluorescence (FAF) in eyes with ea...
PURPOSE: To test the hypothesis that the extension of areas with increased fundus autofluorescence (...
Purpose: To investigate the autofluorescence lifetimes as well as spectral characteristics of soft d...
PURPOSE. To evaluate the relationships between RPE, photoreceptor, and choroidal degeneration in cho...
PURPOSE:To assess the 5-year change in abnormal fundus autofluorescence (FAF) patterns and retinal s...
Purpose: to investigate the pattern of fundus autofluorescence and the correlation with the genotyp...
Purpose: To characterize defects in color vision in patients with choroideremia.Design: Prospective ...
PURPOSE:To describe and classify patterns of abnormal fundus autofluorescence (FAF) of patients with...
Purpose: Centripetal retinal degeneration in choroideremia (CHM) leads to early visual field restric...